Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cytoskeleton disorganization is an early step in the activation process of matrix metalloproteinase 2 (MMP-2) by membrane type 1
MMP
(MT1-MMP) but is also associated with endoplasmic reticulum (ER) dysfunction and subsequent cell death. Given evidence that the ER-embedded
glucose-6-phosphate transporter
(
G6PT
) regulates glioblastoma cell survival and that MT1-
MMP
is a key enzyme in the cancer cell invasive phenotype, we explored the molecular link between
G6PT
and MT1-
MMP
. Cytoskeleton-disrupting agents such as concanavalin A (ConA) and cytochalasin D triggered proMMP-2 activation and cell death in U87 glioma cells. ConA decreased
G6PT
gene expression, an event that was also observed in cells overexpressing the full-length recombinant MT1-
MMP
protein. Overexpression of a membrane-bound catalytically active but cytoplasmic domain-deleted MT1-
MMP
was unable to downregulate
G6PT
gene expression or to trigger necrosis. Gene silencing of MT1-
MMP
with small interfering RNA prevented proMMP-2 activation and induced
G6PT
gene expression. ConA inhibited Akt phosphorylation, whereas overexpression of recombinant
G6PT
rescued the cells from ConA-induced proMMP-2 activation and increased Akt phosphorylation. Altogether, new functions of MT1-
MMP
in cell death signaling may be linked to those of
G6PT
. Our study indicates a molecular signaling axis regulating the invasive phenotype of brain tumor cells and highlights a new "bioswitch" function for
G6PT
in cell survival.
...
PMID:Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. 1746 Jul 77
Mesenchymal stromal cells (MSC) mobilization and recruitment by experimental vascularizing tumors involves membrane type 1-matrix metalloproteinase (MT1-MMP) functions. Given that the mannose-specific lectin Concanavalin-A (ConA) induces MT1-
MMP
expression and mimics biological lectins/carbohydrate interactions, we synthesized and tested the potential of 11 mannoside clusters to block ConA activities on MSC. We found that tetra- and hexavalent mannosides reversed ConA-mediated changes in MSC morphology and antagonized ConA-induced caspase-3 activity and proMMP-2 activation. Tetra- and hexavalent mannosides also inhibited ConA- but not the cytoskeleton disrupting agent Cytochalasin-d-induced MT1-
MMP
cell surface proteolytic processing mechanisms, and effects on cell cycle phase progression. The antiproliferative and pro-apoptotic impact of ConA on the MT1-
MMP
/
glucose-6-phosphate transporter
signaling axis was also reversed by these mannosides. In conclusion, we designed and identified glycocluster constructions that efficiently interfered with carbohydrate-binding proteins (lectins) interaction with oligosaccharide moieties of glycoproteins at the cell surface of MSC. These glycoclusters may serve in carbohydrate-based anticancer strategies through their ability to specifically target MT1-
MMP
pleiotropic functions in cell survival, proliferation, and extracellular matrix degradation.
...
PMID:Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells. 1806 11
The contributions of membrane type-1 matrix metalloproteinase (MT1-MMP) and of the
glucose-6-phosphate transporter
(
G6PT
) in sphingosine-1-phosphate (S1P)-mediated Ca(2+) mobilization were assessed in glioblastoma cells. We show that gene silencing of MT1-
MMP
or
G6PT
decreased the extent of S1P-induced Ca(2+) mobilization, chemotaxis, and extracellular signal-related kinase phosphorylation. Chlorogenic acid and (-)-epigallocatechin-3-gallate, two diet-derived inhibitors of
G6PT
and of MT1-
MMP
, respectively, reduced S1P-mediated Ca(2+) mobilization. An intact MT1-
MMP
/
G6PT
signaling axis is thus required for efficient Ca(2+) mobilization in response to bioactive lipids such as S1P. Targeted inhibition of either MT1-
MMP
or
G6PT
may lead to reduced infiltrative and invasive properties of brain tumor cells.
...
PMID:Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. 1826 20